HOME › DRUGS › MINOCYCLINE HYDROCHLORIDE
ACTIVE SUBSTANCE / INN

MINOCYCLINE HYDROCHLORIDE

Brand name(s): MINOLIRA, AMZEEQ, SOLODYN, EMROSI, XIMINO, MINOCIN, MINOCYCLINE HYDROCHLORIDE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA065005
NDA209269
ACTIVE SUBSTANCE
Minocycline Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
REMPEX, IMPAX LABS, JOURNEY
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
MINOCYCLINE HYDROCHLORIDEANDA090911PHARMOBEDIENTDiscontinued
XIMINONDA201922JOURNEYDiscontinued
AMZEEQNDA212379JOURNEYPrescription
MINOCINNDA050444REMPEXPrescription
MINOCYCLINE HYDROCHLORIDEANDA065005IMPAX LABSPrescription
MINOCINNDA050315TRIAX PHARMSDiscontinued
MINOCYCLINE HYDROCHLORIDEANDA090422SANDOZNone (Tentative Approval)
EMROSINDA219015JOURNEYPrescription
SOLODYNNDA050808BAUSCHDiscontinued
MINOLIRANDA209269EPI HLTHDiscontinued

FULL INTELLIGENCE ON MINOCYCLINE HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →